Paper6889863
The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
Daley-Yates PT and 1 other. Biochem Pharmacol, 1982. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid. Papers, record 6889863. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6889863
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Furosemide | Major topic |
| Kidney | Major topic |
| Probenecid | Major topic |
| Animals | |
| Glomerular Filtration Rate | |
| In Vitro Techniques | |
| Male | |
| Metabolic Clearance Rate | |
| Rats | |
| Rats, Inbred Strains |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32410451 | A Platinum(IV) Prodrug-Perfluoroaryl Macrocyclic Peptide Conjugate Enhances Platinum Uptake in the Brain. | J Med Chem | 2020 | https://conductscience.org/library/papers/32410451 | PubMed |
| 31857146 | Predicting tubular reabsorption with a human kidney proximal tubule tissue-on-a-chip and physiologically-based modeling. | Toxicol In Vitro | 2020 | https://conductscience.org/library/papers/31857146 | PubMed |
| 27210744 | Biodegradable Magnesium (Mg) Implantation Does Not Impose Related Metabolic Disorders in Rats with Chronic Renal Failure. | Sci Rep | 2016 | https://conductscience.org/library/papers/27210744 | PubMed |
| 24371467 | Protective Effect of Standardized Extract of Ginkgo biloba against Cisplatin-Induced Nephrotoxicity. | Evid Based Complement Alternat Med | 2013 | https://conductscience.org/library/papers/24371467 | PubMed |
| 23917312 | Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23917312 | PubMed |
| 22448619 | Impact of obesity on drug metabolism and elimination in adults and children. | Clin Pharmacokinet | 2012 | https://conductscience.org/library/papers/22448619 | PubMed |
| 10554102 | Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats. | Pharm Res | 1999 | https://conductscience.org/library/papers/10554102 | PubMed |
| 8261581 | WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8261581 | PubMed |
| 7497595 | A phase I trial of 5-day continuous infusion cisplatin and interferon alpha. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7497595 | PubMed |
| 4053272 | Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II). | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053272 | PubMed |
| 4040567 | Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat. | J Pharmacokinet Biopharm | 1985 | https://conductscience.org/library/papers/4040567 | PubMed |
| 3383986 | Effect of methotrexate on the pharmacokinetics and renal excretion of cisplatin. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3383986 | PubMed |
| 2909288 | Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2909288 | PubMed |
| 2729945 | Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2729945 | PubMed |
| 1459833 | Calcium blockers enhance cisplatin-induced nephrotoxicity in rats. | Int Urol Nephrol | 1992 | https://conductscience.org/library/papers/1459833 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6889863
GET https://conductscience.org/api/papers/v1/6889863/authors